On October 22nd, the 4th Beijing-Tianjin-Hebei Intelligent Pharmaceutical Innovation Forum was successfully held in Tianjin, co-organized by the Beijing Municipal Bureau of Economy and Information Technology, the Tianjin Municipal Bureau of Industry and Information Technology, the Tianjin Municipal Science and Technology Bureau, and the Hebei Provincial Department of Industry and Information Technology, and the Tianjin Economic development zone management committee, the Beijing-Tianjin-Hebei National Technology Innovation Center, and the Tianjin International Biomedical Joint Research Institute. Professor Huang Yalou, Secretary of the Party Committee of Tianjin International Biomedical Joint Research Institute, Zhang Guihua, Director of Tianjin Binhai New Area Science and Technology Bureau, Dr. Luo Lin, Deputy Director of Beijing-Tianjin-Hebei National Technology Innovation Center, Lv Yunfei, Deputy Director of Tianjin Science and Technology Innovation development Center, Secretary of the Party Committee of Waterdrop Company, General Manager of Waterdrop Chip and Medical Business Group, were invited to attend.
With the innovation and development of the intelligent pharmaceutical industry as the core, and with the purpose of promoting the application of artificial intelligence and data technology in the innovation of medicine and medical technology, this forum explores the more in-depth integration of intelligent technology and medical technology in the epidemic and post-epidemic era, and at the same time, shares the latest domestic industry development in the field of intelligent medicine, displays important technological achievements, seeks industrial development needs, and meets opportunities and challenges.
At the meeting, Hu Yao, general manager of Shui Di Chip and Medical Business Group, delivered a speech on the theme of "intelligent technology to help patients with serious diseases have medical treatment". He pointed out that as of now, more than 2 million patients with difficulties and serious diseases have launched fundraising through water drop fundraising, and the total amount of fundraising has reached 42.8 billion yuan. Among the fundraising patients, 60.4% are men, the age is mainly 45-60 years old, all over the country, 84.5% are distributed in third-tier cities and below; 32.1% of the annual family income of more than 30,000 yuan. The fundraising patients are located all over the country, covering all the top three hospitals, of which 51.2% of the patients are treated in first- and second-tier cities.
In the water drop chip, the diseases suffered by fundraising patients are mainly malignant tumors and acute trauma, malignant cancer accounts for about 1/3, of which lung cancer, liver cancer, breast cancer patients are the most common; rare disease patients also account for a certain proportion, systemic myasthenia gravis, amyotrophic lateral sclerosis and hemophilia are more common.
"Our patients are almost all over every hospital in China, which is a more comprehensive and extensive data sample nationwide, although our positioning is not to precipitate a clinical research-level medical data center, but because it (water drop medical data center) has a wide coverage, a variety of major diseases including some diseases subdivided have statistics, its breadth will give us a lot of space to carry out data insights, market analysis, real event research, retrospective research to bring very different value." Hu Yao said.
In terms of using the water drop medical data center to help patients find clinical innovative drugs, Hu Yao said that in recent years, China's innovative drugs have developed very well, many research centers have developed a large number of new drugs, and many clinical efficiencies are decreasing significantly, but there is a key problem, and many clinical projects cannot find suitable patients. "In the past five years, many pharmaceutical research centers have come to us to help seek clinical project patients, and in the second half of last year, we officially launched the business of helping fundraising patients find new clinical drugs. The advantage of water drops is based on the use of algorithms + manual operation scoring in medical data centers to match items for patients and improve the efficiency of treatment. ”
It is reported that all along, the water drop company has maintained a high frequency of research and research with the National Medical Insurance Bureau, universities, major hospitals and some pharmaceutical companies and other departments, in addition to the use of Internet technology to help patients with serious illness and difficulties to raise money, the water drop medical data center will also precipitate the medical data, as an important data asset of the water drop company, to make more contributions to the development of the industry.
"Helping patients with serious illnesses and difficulties to raise money, find medicines, provide medication benefits, innovate payment methods through links between medical and pharmaceutical insurance, and establish a full-life cycle health management platform centered on serving patients, this is what Waterdrop wants to do." Hu Yao said.
Related: About Waterdrop Company
Founded in April 2016, Waterdrop is China's leading insurance + health service technology platform, with the mission of "using Internet technology to help the broad masses of people have insurance and medical treatment, and protect hundreds of millions of families", and is committed to providing users with health protection solutions. Driven by medical big data, Waterdrop has established cooperation with more than 10 professional research institutes, more than 20 leading domestic and foreign innovative drug enterprises, more than 60 well-known insurance companies, more than 70 top hospitals/departments, and more than 100 public welfare organizations to dig deep into data around clinical research, Internet medical treatment, innovative payment, health management and other directions, and provide patients with medical and health services throughout the life cycle.
(Yan Durong media reporter Hu Yanshicong)